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Background: Second hand tobacco smoke (SHS) and overweight/obesity are risk factors for asthma and
lower airway respiratory symptoms. We investigated whether SHS or overweight/obesity were also
associated with allergic or non-allergic rhinitis.
Methods: Cross-sectional data were obtained during the second SAPALDIA Study. Interviewer adminis-
tered questionnaires were completed by 8047 participants from 8 communities in Switzerland. Blood
was collected from 5841 participants and tested for allergen speciﬁc IgE. Allergic rhinitis was deﬁned as
nasal symptoms with detectable IgE. Data were analysed by multinomial logistic regression with four
outcome categories deﬁned according to the presence or absence of rhinitis and/or atopy.
Results: The prevalence of allergic rhinitis was 885 (15.2%) and non-allergic rhinitis 323 (5.5%). The risk
of allergic rhinitis was increased in subjects with physician diagnosed asthma (Relative Risk Ratio 6.81;
95%CI 5.39, 8.6), maternal atopy (1.56; 1.27, 1.92) and paternal atopy (1.41; 1.11, 1.79). Older subjects were
at lower risk (0.96; 0.95,0.97 per year), as were those raised on a farm (0.64; 0.49,0.84), with older
siblings (0.92; 0.86,0.97 per sib) or from rural areas. The risk of non-allergic rhinitis was also increased in
subjects with physician diagnosed asthma (4.02; 2.86, 5.67), reduced in males (0.59; 0.46, 0.77), but not
associated with upbringing on a farm or older siblings. There were no signiﬁcant associations of SHS or
overweight/obesity with either form of rhinitis.
Conclusions: Allergic and non-allergic rhinitis have different risk factors apart from asthma. There are
signiﬁcant regional variations within Switzerland, which are not explained by the factors examined.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Vic 3004, Australia.
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Rhinitis is characterised by nasal symptoms such as rhinorrhoea,
post-nasal drip, sneezing, obstruction and/or pruritus. The ARIA
(Allergic Rhinitis in Asthma) classiﬁcation1 includes infectious,
allergic, occupational, drug induced and hormonal rhinitis. There
are also other rarer causes including the non-allergic rhinitis with
eosinophilia syndrome, irritant, food-related and atrophic rhinitis.
Epidemiological studies todate have focussed on allergic rhinitis,2e4
which is highly prevalent in many Western countries5 and causes
considerable impairment of quality of life.6 The median fraction
attributable to atopy (population attributable risk) was 27%,5 which
means that other risk factors for rhinitis must also be important.
Second hand (or environmental tobacco) smoke (SHS) exposure
is associated with lower respiratory symptoms, asthma and dec-
rements in lung function. Both active smoking and SHS may in-
crease the risk of chronic rhinitis.7,8 However the results of studies
of active and passive smoking on allergic rhinitis have been con-
ﬂicting. Obesity and overweight are associated with lower respi-
ratory symptoms and several studies have suggested that this
increasingly common condition is associated with asthma, partic-
ularly non-allergic asthma.9 This could provide a partial explana-
tion for the increase in the prevalence of asthma that has been
observed in Western countries over the last 50 years. Longitudinal
analysis of data from the Tasmanian longitudinal Health Study
(TAHS) found that adiposity at 7 years was associated with current
asthma at 32 years of age, particularly in women.10 However much
less is known about the possible role of obesity/overweight in
rhinitis.
The aims of the present analysis of data from the Swiss Cohort
Study on Air Pollution and Lung and Heart Diseases in Adults
(SAPALDIA) were to address the following questions:
1. Does second hand smoke (SHS) increase the risk of allergic or
non-allergic rhinitis?
2. Does obesity/overweight increase the risk of allergic or non-
allergic rhinitis?
3. Are any associations independent of demographic factors,
family history, asthma, occupational and early life exposures?Methods
Subjects
SAPALDIA enrolled 9651 Swiss adults aged between 18 and
60 years at baseline in 1991. Subjects in the present analysis were
participants in the second SAPALDIA study conducted from 2001 to
2003, when weight was measured and blood collected for allergic
and other markers. The detailed methods and characteristics of
participants have been described elsewhere.11 However brieﬂy, an
interviewer administered questionnaire similar to that used in the
European Community Respiratory Health Survey (ECHRS)12 was
completed by 8047 participants from 8 communities around
Switzerland (Basel, Wald, Davos, Lugano, Montana, Payerne, Aarau
and Geneva) (Fig. 1). A health examination was agreed to by 6528
participants and 5973 completed the entire protocol. The studywas
approved by the Swiss Academy of Medical Sciences and ethics
committees of all regional study sites. Written informed consent
was obtained from all study participants.
Deﬁnitions
Exposure to second hand smoke (SHS) was deﬁned as a positive
response to the following question: Have you been regularlyexposed to tobacco smoke in the last 12 months? This deﬁnition
has been previously used in SAPALDIA.13 Overweight was deﬁned
as 25  Body Mass Index (BMI) < 30 kg/m2 and obesity as
BMI  30 kg/m2.14
The outcome of rhinitis was deﬁned as a positive response to the
question: Do you have any nasal allergies including hay fever?
Asthma was deﬁned as positive responses to: Have you ever had
asthma? and Was this conﬁrmed by a doctor?
Atopy was considered an effect modiﬁer. Blood was taken from
5841 participants and assayed for total and allergen speciﬁc IgE
in vitro. The polyvalent Phadiatop™ assay detected allergen speciﬁc
IgE  0.35 kUA/L to any of 11 allergens [Cladosporium, Dermato-
phagoides pteronyssinus, Dermatophagoides farinae, cat, dog, horse,
birch, timothy, olive, mugwort, Parietaria judaica].
Allergic rhinitis was deﬁned as a positive answer to the rhinitis
question together with a positive Phadiatop™. Non-allergic
rhinitis was deﬁned as a positive answer to the rhinitis question,
with a negative Phadiatop™.
Parental atopywas deﬁned as a positive response to either of the
following questions: Did your mother ever have eczema, skin or
nasal allergy or hay fever? Did your father ever have eczema, skin or
nasal allergy or hay fever?
Statistical analysis
This commenced with a cross-sectional analysis of the data on
rhinitis from SAPALDIA2. Univariate associations with the extent of
participation or type of rhinitis were assessed in contingency tables
with c2 tests. Comparisons between groups were made by analysis
of variance or non-parametric equivalents if distributional as-
sumptions were not satisﬁed. Multinomial logistic regression
models were then ﬁtted with four outcome categories deﬁned ac-
cording to the presence or absence of rhinitis and/or atopy. Forward
entry was used with stepwise selection based on the likelihood
ratio test. Initial selection of covariates was guided by the literature
and prior knowledge. Covariates included: demographic e age, sex,
level of education, nationality (Swiss/other); family history e
maternal or paternal asthma or atopy; occupation e self reported
exposure to vapours, gas, dust or fumes; early childhood “hygiene”
e number of older siblings, early respiratory infections, farm resi-
dence and day care attendance; and active smoking e non-smoker,
ex-smoker or current smoker. Sensitivity analyses were conducted
and covariates retained in the models if they altered the OR by 10%.
Doctor diagnosed asthma was initially ﬁtted as a covariate, and
subsequently examined as a stratiﬁcation variable. The effect esti-
mates from the multinomial logistic models were expressed as
Relative Risk Ratios (RRR) and 95% conﬁdence intervals (95%CI),
relative to the group with no rhinitis or atopy. RRR can be inter-
preted as odds ratios conditional on having observed either the
reference outcome or the outcome in question. Analyses were
conducted in SPSS (version 19, IBM, Armonk NY 2010) and SAS
(version 9.3, SAS Institute Inc., Cary NC, USA, 2011).
Results
Description of subjects
Of the 8047 participants in this follow-up study, 4180 (51.9%)
were female and 3867 (48.1%) male. The mean (SD) age at this
examinationwas 52.1 (11.6) years. Mean BMI was 25.9 (4.45) kg/m2,
thus 2494 (25.8%) were classiﬁed as overweight and 1068 (11.1%)
obese. The educational level of 2082 (25.9%) participants was
considered high (University or technical college), 5257 (65.4%) in-
termediate (middle school or apprenticeship) and 702 (8.7%) low
(primary and/or secondary school). Doctor diagnosed asthma was
Fig. 1. SAPALDIA study regions.
Table 1
Differences between participants who only completed the questionnaire and those
who also provided blood to be tested for IgE.
Questionnaire
only (n ¼ 2212)
Full participation
(n ¼ 5835)
P value
Male sex (%) 1028 (46.5) 2839 (48.7) 0.08
Age e mean (SD) years 51.7 (11.9) 52.2 (11.4) 0.05
BMI e median [IQR] kg/m2 25.5 [22.5, 28.8] 25.4 [22.8, 28.3] 0.45
Overweight/obese (%) 426 (54.6)y 3068 (52.7) 0.32
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never smokers, 2537 (26.3%) former and 2116 (26.3%) current
smokers. Over a quarter (1953 or 25.6%) had been exposed to SHS in
the last 12 months, but only 6.4% reported exposure at work and
mean (SD) daily hours exposed to SHS were 0.78 (2.1). A similar
proportion (1801 or 27.4% of respondents) reported current occu-
pational exposure to vapours, gas, dust or fumes.
A family history of maternal asthmawas reported by 369 (4.6%),
maternal atopy by 1102 (13.7%), paternal asthma by 465 (5.8%) and
paternal atopy by 793 (9.9%) participants in SAPALDIA2. Early life
hygiene factors included 3660 (45.5%) sharing a bedroom in early
childhood, 1831 (22.8%) attending day care, 638 (7.9%) had a severe
respiratory infection before the age of 5 years, 979 (12.2%) were
exposed to maternal smoking and 1038 (15.8%) lived on a farm up
to the age of 5.
Compared to those who only completed the questionnaire,
those who provided blood to be tested for IgE were slightly
younger; were more likely to be Swiss nationals, highly educated,
never smokers and living on a farm up to the age of 5 years.
Conversely they were less likely to be currently exposed to SHS or
maternal smoking during childhood. There were also signiﬁcant
variations in the full participation rate between communities
(p < 0.001). There were no signiﬁcant differences in sex, BMI,
overweight/obese, doctor diagnosed asthma, occupational expo-
sures, number of older siblings or family history (Table 1).Education e high (%) 479 (21.7) 1603 (27.5)
Intermediate (%) 1403 (63.5) 3, 854 (66.1) <0.001
Asthma (%) 232 (10.5) 543 (9.3) 0.11
Smoking e current (%) 691 (31.2) 1425 (24.4)
Former (%) 676 (30.6) 1861 (31.9) <0.001
Exposed to SHS (%) 515 (28.4) 1438 (24.7) 0.002
Occupational exposure to
vapours, gas, dust or fumes (%)
194 (24.8)y 1607 (27.8) 0.08
Maternal atopy (%) 297 (13.5) 805 (13.8) 0.68
Paternal atopy (%) 231 (10.5) 562 (9.6) 0.27
Childhood on farm 98 (12.6)y 940 (16.3) 0.008
Maternal smoking 310 (14.1) 669 (11.5) 0.002
y n ¼ 780.Allergic and non-allergic rhinitis
The prevalence of allergic rhinitis was 885 (15.2%) and non-
allergic rhinitis 323 (5.5%) in 5834 subjects with complete data. A
further 874 (9.1%) were atopic but did not report symptoms of
rhinitis. However a clear majority of subjects did not have rhinitis
or atopy. Key unadjusted differences between these 4 groups are
summarised in Table 2. Females were signiﬁcantly more likely than
males to have non-allergic rhinitis. Allergic rhinitis was more
prevalent in Basel and Geneva than Wald or Payerne. Those withallergic rhinitis were signiﬁcantly younger, had a lower BMI and
were less likely to be overweight/obese. They were also signiﬁ-
cantly more likely to have higher education. The mean [SD] age of
onset of allergic rhinitis was 22.5 [14.2] years which was signiﬁ-
cantly younger than non-allergic rhinitis (35.2 [17.3] years,
p < 0.0001). Doctor diagnosed asthmawas signiﬁcantly more likely
among both allergic and non-allergic rhinitis than the other groups.
Those with allergic rhinitis were signiﬁcantly less likely to be cur-
rent or former smokers. However there were no signiﬁcant differ-
ences between groups in exposure to SHS in the previous 12
months, exposure to SHS at work, daily hours exposed to SHS or
occupational exposure to vapours, gas, dust or fumes.
A family history of maternal or paternal atopy was signiﬁcantly
more likely among those with allergic rhinitis. Maternal asthma
was slightly more common among those with allergic rhinitis, but
Table 2
Description of participants by type of rhinitis. P values relate to comparisons between the four categories (n < 5834 for some analyses because of missing data).
No rhinitis or atopy
(n ¼ 3752)
Atopic only
(n ¼ 874)
Non-allergic rhinitis
(n ¼ 323)
Allergic rhinitis
(n ¼ 885)
P value
Male sex (%) 1774 (47.3) 509 (58.2) 112 (34.7) 444 (50.2) <0.001y
Area e Geneva 181 (58.0) 47 (15.1) 30 (9.6) 54 (17.3)
Aarau 638 (65.6) 134 (13.8) 47 (4.8) 154 (15.8)
Payerne 589 (69.8) 131 (15.5) 54 (6.4) 70 (8.3)
Montana 395 (66.7) 81 (13.7) 23 (3.9) 93 (15.7)
Lugano 536 (62.1) 153 (17.7) 30 (3.5) 144 (16.7)
Davos 260 (63.4) 58 (14.1) 26 (6.3) 66 (16.1)
Wald 751 (66.8) 154 (13.7) 66 (5.9) 153 (13.6)
Basel 402 (56.1) 116 (16.2) 47 (6.6) 151 (21.1) <0.001y
Age e mean (SD) yrs 53.6 (11.2) 51.2 (11.1) 52.8 (10.8) 47.6 (11.5) <0.001z
BMI e median [IQR] kg/m2 25.5 [22.9, 28.4) 25.6 [23.1, 28.7] 25.4 [22.4, 28.9] 24.8 [22.5, 27.4] <0.001x
Overweight/obese (%) 2015(53.8) 481 (55.3) 167 (52.0) 405 (45.9) <0.001y
Education e high (%) 933 (24.9) 248 (28.4) 82 (25.5) 340 (38.5)
Intermediate 2565 (68.4) 566 (64.8) 207 (64.3) 516 (58.4) <0.001y
Asthma (%) 168 (4.5) 115 (13.2) 53 (16.4) 207 (23.4) <0.001y
Smoking e current (%) 933 (24.9) 248 (28.4) 81 (25.1) 163 (18.4)
Former 1237 (33.0) 257 (29.4) 112 (34.7) 255 (28.8) <0.001y
Exposed to SHS (%) 909 (24.2) 241 (27.7) 82 (25.5) 206 (23.4) 0.14y
Occupational exposure to vapours, gas, dust or fumes
(%)
1018 (27.4) 241 (27.8) 87 (27.4) 261 (29.8) 0.53y
Maternal atopy (%) 445 (11.9) 121 (13.8) 50 (15.5) 189 (21.4) <0.001y
Paternal atopy (%) 312 (8.3) 87 (10.0) 36 (11.1) 127 (14.4) <0.001y
Childhood on farm 697 (18.8) 111 (12.8) 55 (17.5) 77 (8.8) <0.001y
Maternal smoking 396 (10.6) 119 (13.7) 38 (11.8) 116 (13.3) 0.022y
y c2 test for comparison of proportions.
z Analysis of variance.
x Kruskal Wallis test.
Table 3
Multinomial logistic models of allergic and non-allergic rhinitis.
Allergic rhinitis Non-allergic rhinitis
RRR 95%CI RRR 95%CI
Male sex 1.08 (0.91, 1.27) 0.59 (0.46, 0.77)
Areay e Geneva 0.78 (0.54, 1.17) 1.30 (0.78, 2.16)
Aarau 0.63 (0.48, 0.83) 0.61 (0.40, 0.94)
Payerne 0.36 (0.26, 0.50) 0.74 (0.48, 1.13)
Montana 0.65 (0.47, 0.89) 0.47 (0.27, 0.80)
Lugano 0.86 (0.65, 1.15) 0.47 (0.29, 0.77)
Davos 0.88 (0.62, 1.24) 0.89 (0.53, 1.50)
Wald 0.70 (0.53, 0.92) 0.75 (0.50, 1.13)
Age (/year) 0.96 (0.95, 0.97) 0.99 (0.98, 1.003)
SHS 0.86 (0.71, 1.03) 1.04 (0.79, 1.37)
Overweight/obese 0.96 (0.81, 1.13) 1.02 (0.80, 1.31)
Older sibs number 0.92 (0.86, 0.97) 0.96 (0.89, 1.04)
Paternal atopy 1.41 (1.11, 1.79) 1.22 (0.84, 1.78)
Maternal atopy 1.56 (1.27, 1.92) 1.18 (0.85, 1.64)
Educationz e high 1.48 (0.94, 2.32) 0.68 (0.42, 1.10)
intermediate 1.02 (0.66, 1.57) 0.57 (0.38, 0.87)
Asthma 6.81 (5.39, 8.60) 4.02 (2.86, 5.67)
Childhood on farm 0.64 (0.49, 0.84) 0.91 (0.66, 1.27)
RRR, Relative Risk Ratio (relative to group with no rhinitis or atopy); SHS, Second
Hand Smoke.
y Basel is reference community.
z Low education is reference category.
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shown). Those without rhinitis or atopy were signiﬁcantly more
likely to have spent the ﬁrst ﬁve years of their lives on a farm.
Maternal smoking during childhood was more likely among those
with allergic rhinitis or atopy alone. There were no signiﬁcant dif-
ferences in severe early respiratory infections or day care atten-
dance between participants with rhinitis or atopy and those
without these conditions.
Multinomial logistic models of allergic and non-allergic rhinitis
are summarised in Table 3. The risk of allergic rhinitis was signiﬁ-
cantly increased in subjects with doctor diagnosed asthma (RRR
6.81; 95%CI 5.39, 8.6), maternal atopy (1.56; 1.27, 1.92) and paternal
atopy (1.41; 1.11, 1.79). Older subjects were at lower risk (0.96; 0.95,
0.97 per year), as were those raised on a farm (0.64; 0.49, 0.84),
with older siblings (0.92; 0.86, 0.97 per sib) or from Aarau, Payerne,
Montana or Wald. The risk of non-allergic rhinitis was also signif-
icantly increased in subjects with doctor diagnosed asthma (4.02;
2.86, 5.67), but reduced in males (0.59; 0.46, 0.77) and those from
Aarau, Montana or Lugano.
There was no signiﬁcant independent association of SHS with
either form of rhinitis. Maternal smoking was not selected to enter
the model. When current smoking was selected by the stepwise
procedure, non-smokers appeared to be at an increased risk of
allergic rhinitis (1.88; 1.51, 2.34), as did former smokers (1.43; 1.12,
1.82). However exposure to SHS was still not signiﬁcantly associ-
ated with either form of rhinitis. This ﬁnding did not change when
the data were stratiﬁed by asthma.
Similarly there was no signiﬁcant independent association of
overweight/obesity with either form of rhinitis. The distributions of
all four outcome groups as a function of BMI in those without or
with asthma are given in Fig. 2a,b respectively.
When the analysis was stratiﬁed by asthma status, BMI in the
non-extreme range was not associated with either form of rhinitis
in non-asthmatics (Fig. 2a). In asthmatics, there was a tendency
for persons with allergic rhinitis to have BMI at the lower end
(Fig. 2b).Discussion
This large population based study has conﬁrmed that allergic
and non-allergic rhinitis have different risk factors, apart from
asthma. However second hand tobacco smoke and overweight/
obesity did not appear to be independent risk factors for either
form of rhinitis. The strongest risk factors for allergic rhinitis were
asthma and a family history of atopy. The risk was lower among
older subjects, which could be due to atopy declining with age or a
cohort effect. The protective effects of older siblings and being
raised on a farm are consistent with the “hygiene” hypothesis.15 The
apparent association with higher education as a proxy for socio-
Fig. 2. Distribution of rhinitis/atopy outcomes as a function of BMI in subjects (a)without (b)with doctor diagnosed asthma. The lowest curve (green circles) gives the proportion of
subjects without rhinitis symptoms or atopy. Second band (between green circles and blue triangles) proportion of subjects with atopy but no rhinitis symptoms. Third band
(between blue triangles and red diamonds) proportion of subjects with rhinitis symptoms but no atopy. Fourth band (between red diamonds and black squares) proportion of
subjects with rhinitis symptoms and atopy.
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Non-allergic rhinitis appeared to be more common in females than
males, similar to non-allergic asthma. Symptoms also appeared to
commence at an older age than in allergic rhinitis.
Striking regional variations in the prevalence of rhinitis and
atopy both within Switzerland16 and around Europe and beyond
have been noted previously.5 The prevalence of allergic and non-allergic rhinitis was generally lower in the rural communities,
consistent with the hygiene hypothesis. However the variation
remained even after accounting for the early life environment,
suggesting that other factors might be responsible. The prevalence
was not consistently lower in alpine communities (Davos, Mon-
tana), suggesting that allergen exposures might be less relevant.
However this is likely to be confounded by selection effects as it is
M.J. Abramson et al. / Allergology International 65 (2016) 192e198 197conceivable that some asthmatics moved to Davos to reduce
allergen exposures.
Second hand smoke (SHS) exposure during childhood was
associated with lower respiratory symptoms, asthma and decre-
ments in lung function among young adults participating in the
European Community Respiratory Health Survey (ECRHS).17 Occu-
pational SHS exposure was also associated with any respiratory
symptom and current asthma in adults.17 Both active smoking and
SHS may increase the risk of chronic rhinitis.7,8 However the results
of studies of smoking on allergic rhinitis have been conﬂicting,
perhaps due to self report bias or “healthy smoker” effects. We
think that avoidance is the most likely explanation for the apparent
protective effect that we observed of current or former smoking on
allergic rhinitis.
The literature to date on overweight/obesity and rhinitis has
been inconclusive. Such a relationship is biologically plausible and
similar to asthma might be mediated through inﬂammatory path-
ways involving cytokines including tumour necrosis factor (TNF).18
One case-control study from China found that obesity was associ-
ated with a 3 fold increase in the risk of allergic rhinitis.19 On the
other hand, a large cross-sectional study of Japanese adults found
that obesity and active smoking were associated with a reduced
risk of rhinitis without asthma,20 which could be due to reverse
causation. An earlier study of Japanese children found that obesity
was associated with a reduced risk of allergic conjunctivitis with or
without allergic rhinitis.21 However there was no overall associa-
tion of BMI with allergic rhinitis per se. So our inability to
demonstrate a simple linear association in Swiss adults is not
altogether surprising. The suggestive evidence of an interaction
between BMI, asthma and allergic rhinitis needs to be studied
further in the context of longitudinal data. In our cross-sectional
analyses, we cannot differentiate whether obesity is protective
against allergic rhinitis in asthmatics or whether persons with
asthma and allergic rhinitis are more likely to adapt a lifestyle and
diet to avoid obesity.
The main strengths of SAPALDIA are the sampling of a nation-
ally representative population and a high retention rate on follow-
up (86% of living persons).11 The use of an objective in vitro test of
allergen speciﬁc IgE to classify atopy is a further strength. Weight
and height were measured, allowing accurate estimation of BMI.
Weaknesses are similar to other previous studies. The diagnosis of
rhinitis or hay fever relied on self report and was subject to
misclassiﬁcation. However this question has been widely used in
the ECRHS.22,5 We concede that the combination of this question
with allergen speciﬁc IgE cannot identify mixed rhinitis.23
Furthermore exposure to SHS and the diagnosis of parental
atopy were also based on self report. Not all subjects who
completed questionnaires provided blood potentially introducing
further selection bias. In particular smokers and those exposed to
SHS were less likely to fully participate. However further analysis
of propensity scores suggested that this did not explain the dif-
ferences in the prevalence of allergic or non-allergic rhinitis be-
tween communities. The present analysis is cross-sectional and
apart from early life exposures cannot clearly establish the
sequence of events.
The major clinical implication of our ﬁndings ﬂows from the
strong association between asthma and rhinitis. We would
encourage clinicians to ask about nasal symptoms in their patients
with asthma. Treating allergic rhinitis can improve asthma control.1
Whilst avoidance of SHS and weight loss are clearly desirable for
individual patients and public health purposes, we would not
expect these measures to have much effect on the risk of rhinitis.
Although this study adds to the evidence supporting the hygiene
hypothesis, there is currently no feasible intervention for primary
prevention of allergies. The signiﬁcant regional variations of rhinitiswithin Switzerland remain unexplained and require further
research.
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